ADVFN - ニュース

S&P 500

5,246.68

0.48%

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

該当コードがありません。

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/15	08 : 54	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ACI	Albertsons Companies Inc
2024/05/15	08 : 52	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ACI	Albertsons Companies Inc
2024/05/15	08 : 52	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:MSI	Motorola Solutions Inc
2024/05/15	08 : 51	Business Wire	ispace EUROPE e CDS sottoscrivono un accordo di servizio sul carico utile per il trasporto sulla Luna di una tecnologia di misurazione precisa della posizione	TSX:9348	iSpace Inc
2024/05/15	08 : 50	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ACI	Albertsons Companies Inc
2024/05/15	08 : 48	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ACI	Albertsons Companies Inc
2024/05/15	08 : 48	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:FORM	FormFactor Inc
2024/05/15	08 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ANIP	ANI Pharmaceuticals Inc
2024/05/15	08 : 47	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:PDFS	PDF Solutions Inc
2024/05/15	08 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:ACI	Albertsons Companies Inc
2024/05/15	08 : 46	PR Newswire (Canada)	Déclaration du premier ministre concernant le décès d'Alice Munro
2024/05/15	08 : 45	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:SYNA	Synaptics Incorporated
2024/05/15	08 : 44	GlobeNewswire Inc.	Discovery Reports First Quarter 2024 Financial Results	DSV.TO
2024/05/15	08 : 44	GlobeNewswire Inc.	Discovery Reports First Quarter 2024 Financial Results	TSX:DSV	Discovery Silver Corp
2024/05/15	08 : 44	PR Newswire (Canada)	Statement by the Prime Minister on the passing of Alice Munro
2024/05/15	08 : 42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:LGND	Ligand Pharmaceuticals Incorporated
2024/05/15	08 : 41	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:DNOW	DNOW Inc
2024/05/15	08 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:MODG	Topgolf Callaway Brands Corp
2024/05/15	08 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:DMRC	Digimarc Corporation
2024/05/15	08 : 36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NYSE:NEUE	Neuehealth Inc
2024/05/15	08 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NYSE:DNOW	DNOW Inc
2024/05/15	08 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TCBK	TriCo Bancshares
2024/05/15	08 : 35	PR Newswire (US)	NEW: 2024 Flavor & Product Trends Announced At Sweets & Snacks Expo
2024/05/15	08 : 34	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:ALTR	Altair Engineering Inc
2024/05/15	08 : 34	Business Wire	ispace EUROPE und CDS unterzeichnen Nutzlastservice-Vereinbarung für den Transport von Technologie für die genaue Bestimmung des Standortes auf dem Mond	TSX:9348	iSpace Inc
2024/05/15	08 : 34	PR Newswire (Canada)	Andlauer Healthcare Group Announces Intention To Commence Substantial Issuer Bid	TSX:AND	Andlauer Heathcare Group Inc
2024/05/15	08 : 33	GlobeNewswire Inc.	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status	XE:IDP	Biogen Inc
2024/05/15	08 : 33	GlobeNewswire Inc.	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status	NASDAQ:BIIB	Biogen Inc
2024/05/15	08 : 33	GlobeNewswire Inc.	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status	TG:IDP	Biogen Inc
2024/05/15	08 : 33	GlobeNewswire Inc.	Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI® (lecanemab-irmb) for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status	LSE:0R1B	Biogen Inc